United States · FDA National Drug Code directory
Ondansetron Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54348-821_eaa58b56-e847-aab7-e053-2995a90a49c2
- Product NDC
- 54348-821
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ondansetron Hydrochloride
- Labeler
- Pharmpak, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190808
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 BOX (54348-821-00) / 1 TABLET, FILM COATED in 1 BOTTLE · 54348-821-00
- 1 BOTTLE in 1 BOX (54348-821-02) / 2 TABLET, FILM COATED in 1 BOTTLE · 54348-821-02
- 1 BOTTLE in 1 BOX (54348-821-04) / 4 TABLET, FILM COATED in 1 BOTTLE · 54348-821-04
- 1 BOTTLE in 1 BOX (54348-821-05) / 5 TABLET, FILM COATED in 1 BOTTLE · 54348-821-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →